Facebook Takes Steps to Curb Sensational Health Claims
(Bloomberg) -- Facebook Inc. said it's taking steps to curb postings about sensational medical or health-related claims, after a report said the social media site and YouTube were being overrun with content containing potentially harmful information about alternative cancer treatments.
The Wall Street Journal conducted an investigation into the two sites, prompting Facebook to address the situation in a blog post Tuesday. The Journal found that widespread misinformation sometimes appeared alongside advertisements, videos or pages for proven treatments.
In a post Tuesday, Facebook said that last month it made two changes to its ranking algorithms to reduce posts with exaggerated or sensational health claims and those attempting to sell products or services based on health-related claims. The company said it's doing this in a way similar to how it's handled other low-quality content: by identifying phrases commonly used in the posts and then showing them lower in the News Feed.
Tech companies are increasingly trying to battle a proliferation of dubious health-related content on their sites, and are also aggressively trying to weed out hate speech and political misinformation.
To contact the reporter on this story: Molly Schuetz in New York at mschuetz9@bloomberg.net
To contact the editors responsible for this story: Jillian Ward at jward56@bloomberg.net, Robin Ajello
©2019 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
